Ad
related to: hepatitis c vaccine development
Search results
Results from the WOW.Com Content Network
A hepatitis C vaccine, a vaccine capable of protecting against the hepatitis C virus (HCV), is not yet available. Although vaccines exist for hepatitis A and hepatitis B, development of an HCV vaccine has presented challenges. [1] No vaccine is currently available, but several vaccines are currently under development. [2] [3]
As of 2011, there are about one hundred medications in development for hepatitis C. [147] These include vaccines to treat hepatitis, immunomodulators, and cyclophilin inhibitors, among others. [162] These potential new treatments have come about due to a better understanding of the hepatitis C virus. [163]
Pablo Valenzuela (Latin American Spanish: [ˈpaβlo βalenˈswela]; born June 13, 1941) is a Chilean biochemist dedicated to biotechnology development. [2] He is known for his genetic studies of hepatitis viruses; participated as R&D Director in the discovery of hepatitis C virus and the invention of the world's first recombinant vaccine (against hepatitis B virus).
Prevention truly is your best medicine for hepatitis C because unlike its cousins, hepatitis A and B, hepatitis C has no vaccine. ... showed proof of concept for the development of a vaccine. But ...
Inovio Pharmaceuticals (INO) and Korean partner GeneOne Life Science dose the first patient in a phase I study, which will assess its hepatitis C vaccine GLS-6150.
Vertex Announces Presentation of New Data from Hepatitis C Development Program at AASLD Annual Meeting CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (NAS: VRTX) today ...
The hepatitis C virus (HCV) [3] is a small (55–65 nm in size), enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. The hepatitis C virus is the cause of hepatitis C and some cancers such as liver cancer ( hepatocellular carcinoma , abbreviated HCC) and lymphomas in humans.
Biotech firm Idenix Pharmaceuticals announced Monday that it will not continue developing two of its pipeline drugs: hepatitis C therapy IDX184, which was in phase 2B clinical trial, and another ...
Ad
related to: hepatitis c vaccine development